178 related articles for article (PubMed ID: 15203156)
1. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
4. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
Blizzard TA; DiNinno F; Chen HY; Kim S; Wu JY; Chan W; Birzin ET; Yang YT; Pai LY; Hayes EC; DaSilva CA; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2005 Sep; 15(17):3912-6. PubMed ID: 15993065
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
Tan Q; Blizzard TA; Morgan JD; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; Warrier S; Yudkovitz J; Wilkinson HA; Sharma N; Fitzgerald PM; Li S; Colwell L; Fisher JE; Adamski S; Reszka AA; Kimmel D; DiNinno F; Rohrer SP; Freedman LP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2005 Mar; 15(6):1675-81. PubMed ID: 15745820
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains.
Tan Q; Birzin ET; Chan W; Tien Yang Y; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jul; 14(14):3747-51. PubMed ID: 15203155
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
Blizzard TA; DiNinno F; Morgan JD; Wu JY; Chen HY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Zhang Z; Hayes EC; DaSilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Aug; 14(15):3865-8. PubMed ID: 15225686
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
Kim S; Wu J; Chen HY; Birzin ET; Chan W; Yang YT; Colwell L; Li S; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jun; 14(11):2741-5. PubMed ID: 15125925
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
12. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
[TBL] [Abstract][Full Text] [Related]
13. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.
Chen HY; Kim S; Wu JY; Birzin ET; Chan W; Yang YT; Dahllund J; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 May; 14(10):2551-4. PubMed ID: 15109649
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 3-alkyl naphthalenes as novel estrogen receptor ligands.
Fang J; Akwabi-Ameyaw A; Britton JE; Katamreddy SR; Navas F; Miller AB; Williams SP; Gray DW; Orband-Miller LA; Shearin J; Heyer D
Bioorg Med Chem Lett; 2008 Sep; 18(18):5075-7. PubMed ID: 18722117
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
[TBL] [Abstract][Full Text] [Related]
17. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification.
Richardson TI; Dodge JA; Durst GL; Pfeifer LA; Shah J; Wang Y; Durbin JD; Krishnan V; Norman BH
Bioorg Med Chem Lett; 2007 Sep; 17(17):4824-8. PubMed ID: 17614275
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
19. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
Mewshaw RE; Bowen SM; Harris HA; Xu ZB; Manas ES; Cohn ST
Bioorg Med Chem Lett; 2007 Feb; 17(4):902-6. PubMed ID: 17188490
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
Blizzard TA; Dininno F; Morgan JD; Chen HY; Wu JY; Kim S; Chan W; Birzin ET; Yang YT; Pai LY; Fitzgerald PM; Sharma N; Li Y; Zhang Z; Hayes EC; Dasilva CA; Tang W; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2005 Jan; 15(1):107-13. PubMed ID: 15582421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
